1. Aplicación de los contratos de riesgo compartido a la financiación de nuevos medicamentos;Puig-Junoy;Gestión Clínica y Sanitaria,2004
2. Can’t get no satisfaction? Will pay for performance help? Toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products;Towse;Pharmacoeconomics,2010
3. The Pharmaceutical Price Regulation Scheme. December 2008. [consultado 11/4/2010]. Disponible en: www.dh.gov.uk/pprs
4. Carlson JJ, Sullivan SD, Garrison LP, et al. Linking payment and health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health Policy. 2010;96:179–90.
5. Espín J, Rovira J. Analysis of differences and commonalities in pricing and reimbursement systems in Europe. A study funded by DG Enterprise and Industry of the European Commission, EASP Final Report, June 2007. [consultado 1/4/2010]. Disponible en: http://ec.europa.eu/enterprise/phabiocom/docs/study_pricing_2007/andalusian_school_public_health_report_pricing_2007_incl_annexes.pdf